ID   SETX_MOUSE              Reviewed;        2646 AA.
AC   A2AKX3; A2AKX4; A2AR33; Q6IMG6; Q6PED8; Q6ZQ81; Q80V90; Q8C5P1; Q8C859;
AC   Q8C8P6;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 1.
DT   07-APR-2021, entry version 107.
DE   RecName: Full=Probable helicase senataxin {ECO:0000305};
DE            EC=3.6.4.-;
DE   AltName: Full=Amyotrophic lateral sclerosis 4 protein homolog;
DE   AltName: Full=SEN1 homolog;
GN   Name=Setx {ECO:0000312|MGI:MGI:2443480}; Synonyms=Als4, Kiaa0625;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1050 (ISOFORM 2), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-858 (ISOFORM 1), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 2464-2646.
RC   STRAIN=C57BL/6J; TISSUE=Head, Retina, and Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1745-2646 (ISOFORM 1).
RC   STRAIN=129, and C57BL/6J; TISSUE=Brain, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1915-2646 (ISOFORM 1).
RC   TISSUE=Embryonic tail;
RX   PubMed=14621295; DOI=10.1093/dnares/10.4.167;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: III.
RT   The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 10:167-180(2003).
RN   [5]
RP   IDENTIFICATION (ISOFORM 1).
RC   STRAIN=C57BL/6J;
RX   PubMed=14770181; DOI=10.1038/ng1303;
RA   Moreira M.-C., Klur S., Watanabe M., Nemeth A.H., Le Ber I., Moniz J.-C.,
RA   Tranchant C., Aubourg P., Tazir M., Schoels L., Pandolfo M., Schulz J.B.,
RA   Pouget J., Calvas P., Shizuka-Ikeda M., Shoji M., Tanaka M., Izatt L.,
RA   Shaw C.E., M'Zahem A., Dunne E., Bomont P., Benhassine T., Bouslam N.,
RA   Stevanin G., Brice A., Guimaraes J., Mendonca P., Barbot C., Coutinho P.,
RA   Sequeiros J., Duerr A., Warter J.-M., Koenig M.;
RT   "Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-
RT   ocular apraxia 2.";
RL   Nat. Genet. 36:225-227(2004).
RN   [6]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16644229; DOI=10.1016/j.nbd.2006.02.007;
RA   Chen Y.-Z., Hashemi S.H., Anderson S.K., Huang Y., Moreira M.-C.,
RA   Lynch D.R., Glass I.A., Chance P.F., Bennett C.L.;
RT   "Senataxin, the yeast Sen1p orthologue: characterization of a unique
RT   protein in which recessive mutations cause ataxia and dominant mutations
RT   cause motor neuron disease.";
RL   Neurobiol. Dis. 23:97-108(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102; SER-870; SER-871;
RP   SER-872; SER-1002; SER-1004; SER-1472 AND THR-1474, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [8]
RP   FUNCTION IN CIRCADIAN RHYTHMS, AND INTERACTION WITH PER2.
RX   PubMed=22767893; DOI=10.1126/science.1221592;
RA   Padmanabhan K., Robles M.S., Westerling T., Weitz C.J.;
RT   "Feedback regulation of transcriptional termination by the mammalian
RT   circadian clock PERIOD complex.";
RL   Science 337:599-602(2012).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=23593030; DOI=10.1371/journal.pgen.1003435;
RA   Becherel O.J., Yeo A.J., Stellati A., Heng E.Y., Luff J., Suraweera A.M.,
RA   Woods R., Fleming J., Carrie D., McKinney K., Xu X., Deng C., Lavin M.F.;
RT   "Senataxin plays an essential role with DNA damage response proteins in
RT   meiotic recombination and gene silencing.";
RL   PLoS Genet. 9:E1003435-E1003435(2013).
CC   -!- FUNCTION: Probable RNA/DNA helicase involved in diverse aspects of RNA
CC       metabolism and genomic integrity. Plays a role in transcription
CC       regulation by its ability to modulate RNA Polymerase II (Pol II)
CC       binding to chromatin and through its interaction with proteins involved
CC       in transcription. Contributes to the mRNA splicing efficiency and
CC       splice site selection. Required for the resolution of R-loop RNA-DNA
CC       hybrid formation at G-rich pause sites located downstream of the
CC       poly(A) site, allowing XRN2 recruitment and XRN2-mediated degradation
CC       of the downstream cleaved RNA and hence efficient RNA polymerase II
CC       (RNAp II) transcription termination (By similarity). Required for the
CC       3' transcriptional termination of PER1 and CRY2, thus playing an
CC       important role in the circadian rhythm regulation (PubMed:22767893).
CC       Involved in DNA double-strand breaks damage response generated by
CC       oxidative stress. In association with RRP45, targets the RNA exosome
CC       complex to sites of transcription-induced DNA damage (By similarity).
CC       Plays a role in the development and maturation of germ cells: essential
CC       for male meiosis, acting at the interface of transcription and meiotic
CC       recombination, and in the process of gene silencing during meiotic sex
CC       chromosome inactivation (MSCI) (PubMed:23593030). Plays a role in
CC       neurite outgrowth in hippocampal cells through FGF8-activated signaling
CC       pathways. Inhibits retinoic acid-induced apoptosis. May be involved in
CC       telomeric stability through the regulation of telomere repeat-
CC       containing RNA (TERRA) transcription (By similarity).
CC       {ECO:0000250|UniProtKB:Q7Z333, ECO:0000269|PubMed:22767893,
CC       ECO:0000269|PubMed:23593030}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with PER2; the
CC       interaction inhibits termination of circadian target genes
CC       (PubMed:22767893). Interacts with CHD4, POLR2A, PRKDC and TRIM28. Does
CC       not interact with C14orf178. Interacts with UBE2I. Interacts (via N-
CC       terminus domain) with EXOSC9 (via C-terminus region); the interaction
CC       enhances SETX sumoylation. Interacts with NCL (via N-terminus domain).
CC       Interacts with PABPN1, PABPC1 and SF3B1. Interacts with SMN1/SMN2 and
CC       POLR2A; SMN1/SMN2 recruits SETX to POLR2A (By similarity).
CC       {ECO:0000250|UniProtKB:Q7Z333, ECO:0000269|PubMed:22767893}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q7Z333}. Nucleus,
CC       nucleoplasm {ECO:0000269|PubMed:16644229}. Nucleus, nucleolus
CC       {ECO:0000269|PubMed:16644229}. Cytoplasm {ECO:0000269|PubMed:16644229}.
CC       Chromosome {ECO:0000269|PubMed:23593030}. Chromosome, telomere
CC       {ECO:0000250|UniProtKB:Q7Z333}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q7Z333}. Cell projection, growth cone
CC       {ECO:0000250|UniProtKB:Q7Z333}. Note=Most abundant in the nucleus (By
CC       similarity). Detected in granules (By similarity). Colocalized in
CC       cycling cells with FBL in the nucleolus. Localizes with telomeric DNA
CC       in a transcription-dependent manner. Under replication stress,
CC       colocalizes with a variety of DNA damage signaling and repair response
CC       proteins at distinct nuclear foci in mitotic S/G2- and G1-phase cells
CC       in a transcription- and RNA/DNA hybrid-dependent manner. Localizes at
CC       limited number of nuclear foci. Colocalizes with EXOSC9 in nuclear foci
CC       upon induction of transcription-related DNA damage at the S phase (By
CC       similarity). At pachytene stage, colocalizes predominantly to the
CC       heterochromatic XY-body of sex chromosomes with DNA damage response
CC       proteins in a BRCA1-dependent manner (PubMed:23593030). May be detected
CC       in the nucleolus only in cycling cells (PubMed:16644229).
CC       {ECO:0000250|UniProtKB:Q7Z333, ECO:0000269|PubMed:16644229,
CC       ECO:0000269|PubMed:23593030}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=A2AKX3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A2AKX3-2; Sequence=VSP_028827;
CC   -!- TISSUE SPECIFICITY: Expressed in cerebellum, hippocampus, olfactory
CC       bulb, Bergmann glial fibers, stellate cells and Purkinje cells.
CC       Expressed in the epithelial cells of the lens but not in mature lens
CC       fiber cells. Expressed in the retina (highly expressed in inner and
CC       outer segments of photoreceptors and outer plexiform layer cells but
CC       weakly expressed in the inner plexiform and ganglion cell layers).
CC       Expressed in the kidney. {ECO:0000269|PubMed:16644229}.
CC   -!- DOMAIN: The N-terminus domain is necessary for S/G2 nuclear foci
CC       localization. {ECO:0000250|UniProtKB:Q7Z333}.
CC   -!- PTM: Ubiquitinated. {ECO:0000250|UniProtKB:Q7Z333}.
CC   -!- PTM: Sumoylated preferentially with SUMO2 or SUMO3.
CC       {ECO:0000250|UniProtKB:Q7Z333}.
CC   -!- DISRUPTION PHENOTYPE: Mice are viable. Male germ cells proceed normally
CC       from spermatogonia up to the meiotic pachytene stage but fail to enter
CC       into spermiogenesis and form mature spermatids (PubMed:23593030),
CC       resulting in male infertility. In particular, during spermatogenesis,
CC       male germ cells accumulated DNA:RNA hybrids (R-loops), meiotic DNA
CC       double-strand breaks, and fails to produce crossovers and meiotic sex
CC       chromosome inactivation (MSCI) (PubMed:23593030).
CC       {ECO:0000269|PubMed:23593030}.
CC   -!- SIMILARITY: Belongs to the DNA2/NAM7 helicase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC32054.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAC97987.1; Type=Miscellaneous discrepancy; Note=The sequence differs from that shown because it is derived from pre-RNA.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL772379; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL845267; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK044730; BAC32054.1; ALT_FRAME; mRNA.
DR   EMBL; AK048354; BAC33309.2; -; mRNA.
DR   EMBL; AK077911; BAC37058.1; -; mRNA.
DR   EMBL; BC046382; AAH46382.1; -; mRNA.
DR   EMBL; BC058109; AAH58109.2; -; mRNA.
DR   EMBL; BC079604; AAH79604.2; -; mRNA.
DR   EMBL; AK129177; BAC97987.1; ALT_SEQ; Transcribed_RNA.
DR   EMBL; BK001523; DAA01946.1; -; mRNA.
DR   CCDS; CCDS38090.1; -. [A2AKX3-1]
DR   RefSeq; NP_932150.2; NM_198033.2. [A2AKX3-1]
DR   BioGRID; 234629; 10.
DR   DIP; DIP-56995N; -.
DR   IntAct; A2AKX3; 4.
DR   STRING; 10090.ENSMUSP00000051492; -.
DR   iPTMnet; A2AKX3; -.
DR   PhosphoSitePlus; A2AKX3; -.
DR   EPD; A2AKX3; -.
DR   MaxQB; A2AKX3; -.
DR   PaxDb; A2AKX3; -.
DR   PeptideAtlas; A2AKX3; -.
DR   PRIDE; A2AKX3; -.
DR   ProteomicsDB; 257128; -. [A2AKX3-1]
DR   ProteomicsDB; 257129; -. [A2AKX3-2]
DR   Antibodypedia; 31672; 351 antibodies.
DR   Ensembl; ENSMUST00000061578; ENSMUSP00000051492; ENSMUSG00000043535. [A2AKX3-1]
DR   GeneID; 269254; -.
DR   KEGG; mmu:269254; -.
DR   UCSC; uc008izm.1; mouse. [A2AKX3-1]
DR   CTD; 23064; -.
DR   MGI; MGI:2443480; Setx.
DR   eggNOG; KOG1801; Eukaryota.
DR   GeneTree; ENSGT00940000160918; -.
DR   HOGENOM; CLU_000967_0_0_1; -.
DR   InParanoid; A2AKX3; -.
DR   OrthoDB; 62494at2759; -.
DR   PhylomeDB; A2AKX3; -.
DR   TreeFam; TF324634; -.
DR   BioGRID-ORCS; 269254; 0 hits in 53 CRISPR screens.
DR   ChiTaRS; Setx; mouse.
DR   PRO; PR:A2AKX3; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; A2AKX3; protein.
DR   Bgee; ENSMUSG00000043535; Expressed in spermatocyte and 260 other tissues.
DR   ExpressionAtlas; A2AKX3; baseline and differential.
DR   Genevisible; A2AKX3; MM.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0000781; C:chromosome, telomeric region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0030426; C:growth cone; ISS:UniProtKB.
DR   GO; GO:0045171; C:intercellular bridge; ISO:MGI.
DR   GO; GO:0016604; C:nuclear body; ISO:MGI.
DR   GO; GO:0000228; C:nuclear chromosome; ISS:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004386; F:helicase activity; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0003723; F:RNA binding; IBA:GO_Central.
DR   GO; GO:0001147; F:transcription termination site sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; ISS:UniProtKB.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; ISS:UniProtKB.
DR   GO; GO:0034599; P:cellular response to oxidative stress; ISS:UniProtKB.
DR   GO; GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; IMP:MGI.
DR   GO; GO:0006310; P:DNA recombination; IEA:UniProtKB-KW.
DR   GO; GO:0006353; P:DNA-templated transcription, termination; ISS:UniProtKB.
DR   GO; GO:0006302; P:double-strand break repair; ISS:UniProtKB.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0000165; P:MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0006376; P:mRNA splice site selection; ISS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:2000144; P:positive regulation of DNA-templated transcription, initiation; ISS:UniProtKB.
DR   GO; GO:0060566; P:positive regulation of DNA-templated transcription, termination; ISS:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0033120; P:positive regulation of RNA splicing; ISS:UniProtKB.
DR   GO; GO:2000806; P:positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0043491; P:protein kinase B signaling; ISS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0006369; P:termination of RNA polymerase II transcription; IMP:MGI.
DR   CDD; cd18808; SF1_C_Upf1; 1.
DR   InterPro; IPR041679; DNA2/NAM7-like_C.
DR   InterPro; IPR041677; DNA2/NAM7_AAA_11.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF13086; AAA_11; 1.
DR   Pfam; PF13087; AAA_12; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Biological rhythms; Cell projection;
KW   Chromosome; Coiled coil; Cytoplasm; Differentiation; DNA damage;
KW   DNA recombination; DNA repair; Helicase; Hydrolase; Isopeptide bond;
KW   Neurogenesis; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Spermatogenesis; Telomere; Ubl conjugation.
FT   CHAIN           1..2646
FT                   /note="Probable helicase senataxin"
FT                   /id="PRO_0000307777"
FT   NP_BIND         1939..1946
FT                   /note="ATP"
FT                   /evidence="ECO:0000255"
FT   REGION          2632..2646
FT                   /note="Necessary for nuclear localization"
FT                   /evidence="ECO:0000250"
FT   MOTIF           2046..2063
FT                   /note="Bipartite nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         102
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         640
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z333"
FT   MOD_RES         870
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         871
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         872
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         938
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z333"
FT   MOD_RES         1002
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1004
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1318
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z333"
FT   MOD_RES         1472
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1474
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         2450
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z333"
FT   CROSSLNK        339
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z333"
FT   CROSSLNK        1051
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z333"
FT   CROSSLNK        1328
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z333"
FT   CROSSLNK        1329
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z333"
FT   CROSSLNK        1398
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z333"
FT   VAR_SEQ         1..381
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_028827"
FT   CONFLICT        644
FT                   /note="S -> C (in Ref. 2; BAC32054)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1048
FT                   /note="Q -> R (in Ref. 2; BAC33309)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2646 AA;  297589 MW;  3036F84EFED4A098 CRC64;
     MSTCCWCTPG GSSTIDVLKR YASSTGSSEF QTADEDLCYC LECVAEYHRA RDEVPFLHEV
     LWELETLRLV SHFEKSMKAE AEDDDDLYIV DNNGEEQLFD CSGQDFENKL RVPLFEILKY
     PYLLLHERVN ELCVEALCRM EQNNCSFQVF DKYPGIYLFL VHPNEMVRRW AILTARNLGK
     VDRDDYYDLQ EVLTCLFKVI ELGLLESPDI YTSSVLEKGK LILLPAHMYD TTNYKNYWLG
     ICMLLTILEE QAMDSLLLGS DKQNDFMQSI LHTMEKQSDD DSMDPFWPAL HCFMVILDRL
     GSKVWGQLID PIEAFQTIIN NESYNREIQN IRNSSIRTKL EPEPHFDDMV TCSQIVYNFN
     PEKTKKDSGW RSAICPDYCP NMYEEMETLA NVLQSDIGQD MRVHNSTFLW FIPFVQSLMD
     LKDLGVAYIV EVIHHLYSEV KDVLNQTDAV CDKVTEFFIL ILISVIELHR NKKCLHLLWV
     SSQQWVEAVV KCAKLPTTAF VRSCEKSPGS TSRGAAIMSS LALHSVQSNS VQLACVQLIR
     GLLKEGYQLG QQTLCKRFWD KLNLFLRGNL SLGWQLTGQE THELQMCLKQ IIRNIKFKMP
     QYSTFGDSTS TFKTPPSFKE ESDKIDRKHK KNIYCLENCS PVSSKEPMKA DTHRVLMKVN
     TTEEENFKQH YIDLNEEEQE PLPAELCLKQ KSEALFSESA QEQVKISAEK SGKESSSYAP
     SNSTSRNGPE WGCDRGVIMS AHSLTDSSSD FMEQVSTSNE DVSLKDGSVG KTSKPSFKLQ
     KDEICAKLSH VIKKQIRKST LVDNIIDLEE NTAISDLENC SGTDGGALKE DSIGHNVPSD
     PVLDDKHEEQ KSQNSSLFKK EIKSEELDNS SSDDEDKLQI QEGRADDDLV SFTEVTDTLV
     KAPCEGHVKM VVESRDKEMR ESTALTSNLV EGQVPHDSSK PLVAGRQIDL CNITLISQTT
     VIQFPSGLSK QNSFQLQKGD KRCLTANQNS AATCRGQVIV ISDSDEEEDE DEDERSSSEE
     NIKQSKACIG KDCSEHRSLA VNASVEKQLV KEEERYPVEF EDSESQVFEF ESSSEVFSVW
     QDHKIDSKNS LQGEQKSYVT HVADSTNNNL GCGDSVSEEV VRNKAEGVKE HAGPHSSVSA
     EEFCKTGVKK PKRKRYDKVT AEDPQRPSSS VGTDQLPDRR DLTESDLKSA DMGMATPSSS
     VERDSTILQK STKSRTHSKP VRKVPASKAT KKTHSDTRRG QSKSSCYISC RTSPAIVPPK
     KLRQCPEPTS TVEKLGLKKA PRKAFELSQR SLECIVQLRD HGKTVGVVDA PKKAKLISPQ
     TLSIKNNKKL LTSQDLQFQR LMRSRSHKKR DFDYKNTDTV RVSRIVQGSD VLEADSDEPD
     DHRVSEPLAI SNEKQLAKCM LSKTEVAEAS SDPWVTGITC LVNQCESRVL SGGVPTDVVM
     VSASEDPVDG GAVTVQVGEV ASVKAAEPAS SSDTDDDDNL FLTQHDPQDM DLCSQLENKT
     IIVAHKKDTV QREDSLSRPQ LESLSITKCK YKDCVETTKN QGEYCPRHSE AKAADDGLFR
     KPGLPLSVAR PLRPTTTKIF SSSSASRTAN LSKSLESTTL QQSALKNKSS GAQPNLKVTP
     PSSMGSQKPV AEVKSLCNIF HFQTPSSSSK QSCKLTFSEN RPTSAASPVN ILLPSQSIFD
     TFIKEVLKWK YQMFLNFDKC GAPTSLCQSI SRPVPVRFQD CAEYFNVFLP LIILNAFETV
     AQEWLSSPNK ENFYQLQLRK FPADYKKYWE FLIYLNESEL AKQLHPKEND LVFLAPEKSY
     MDRHGMQDCS HYYCGYVHKF RRTSVMRSGK AECSLCIQTQ DTLPASVKNL TRCIVISSLV
     TTQRKLKAMS LLSSRNQLAR AVLNPNPMDF CTKDLLTTTS ERIVAYLKDF NEDQKKAIET
     AYAMVKHSPS VAKICLIHGP PGTGKSKTIV GLLYRLLTEN QRKGHSDENF NAKIKQNRVL
     VCAPSNAAVD ELMKKIILEF KEKCKDKKNP LGNCGDINLV RLGPEKSINT EVLKFSLDSQ
     VNHRMKKDLP SHIQEMLRRK EILDAQLDEL SRQRALCRGG REMQRQELDE HIAIVSKERQ
     ELASKIKEVQ GRPQRAQNTI ILESHVICCT LSTSGGLLLE SAFRGQGGVP FSCVIVDEAG
     QSCEVETLSP LIHRCNKLIL VGDPKQLPPT VISMKAQEYG YDQSMMARFC KLLEENVEQN
     MIGRLPVLQL TIQYRMHPDI CLFPSNYVYN KNLKTNRLTE SIRCSSEWPF QPYLVFDVGD
     GSERRDNDSY INVQEIKLVM EIIKLIKEKR KDISFRNIGI ITHYKAQKTM IQKDLEKEFD
     KKGPAEVDTV DAFQGRQKDC IIVTCVRASA VQGSIGFLAS LQRLNVTITR AKYSLFILGH
     LRTLMENQHW YELIQDAQKR GAIIKTSDPN YRHDAMKILK LKPVLQRSLT HPPATAPEAP
     RPQGGLPSNR LDSGLATTSF AASLYHTPSD TVTSKGPERP LLQDRLRDPR LLRRLDAEAK
     GTFLKDPQPV SPQLPGVVHL LGEPGFPVVF QDLGFVVPPS TAIVAPLGSH RSPMQAEPPP
     AHPAAAASTS KRKYSDPDAG LSHKREPRAF SGEQGRHGSV THHVLRSTDW DRRRLDDSSA
     KRRQFL
//
